ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Temsirolimus
C56H87NO16
1030.3 g/mol
APIDanger

Temsirolimus

CAS162635-04-3
Category
API
Compound Class
Natural Product
Primary Use
Pharmaceutical Raw Material

Temsirolimus is an active pharmaceutical ingredient and a derivative of sirolimus. It is a prodrug used as a compound in pharmaceutical manufacturing for certain oncology applications.

pharmaceutical raw material for renal cell carcinoma therapyprodrug for mammalian target of rapamycin (mTOR) inhibition research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 162635-04-3

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

SimilarStructure SimilarSimilarity 0.85

Everolimus

CAS159351-69-6

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.84

Sirolimus

CAS53123-88-9

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.84

Sirolimus Impurity 2

CAS157182-37-1

Pharmaceutical impurity reference standard

ReferenceSame Category

Zorifertinib

CAS1626387-80-1

pharmaceutical raw material

ReferenceSame Category

Azd-8186

CAS1627494-13-6

pharmaceutical raw material

ReferenceSame Category

[2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridin-5-yl]methanone

CAS1627902-21-9

pharmaceutical raw material

ReferenceSame Category

Caspofungin

CAS162808-62-0

pharmaceutical raw material

Safety Reference

Health Hazard
Health Hazard
Environmental Hazard
Environmental Hazard
Danger
H360May damage fertility or the unborn child
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name

[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate

InChIKey

CBPNZQVSJQDFBE-FUXHJELOSA-N

SMILES

C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC

Synonyms (18)
  • AB01274736-01
  • Cci 779
  • SDCCGSBI-0654330.P001
  • TEMSIROLIMUS [MART.]
  • Temserolimus
  • Temsirolimus
  • Temsirolimus (>80%)
  • Temsirolimus Injection
  • Temsirolimus, >=98% (HPLC)
  • Torisel
  • WAY-CCI 779
  • temsirolimusum